These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10950467

  • 21. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M, Wilkins A, Werstiuk ES, Steiner M.
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [Abstract] [Full Text] [Related]

  • 22. [Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?].
    Dassylva B, Fontaine R.
    Can J Psychiatry; 1995 Mar; 40(2):102-8. PubMed ID: 7788612
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ, Kocsis JH, Ritvo EC, Cutler RB.
    JAMA; 1996 Mar 13; 275(10):761-7. PubMed ID: 8598592
    [Abstract] [Full Text] [Related]

  • 29. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
    Stern SL, Cooper TB, Nelson LD, Johnson MH, Suckow RF.
    Int Clin Psychopharmacol; 1996 Dec 13; 11(4):219-27. PubMed ID: 9031987
    [Abstract] [Full Text] [Related]

  • 30. Phenelzine treatment of melancholia.
    McGrath PJ, Stewart JW, Harrison W, Wager S, Quitkin FM.
    J Clin Psychiatry; 1986 Aug 13; 47(8):420-2. PubMed ID: 3525522
    [Abstract] [Full Text] [Related]

  • 31. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P, Pérez J, Alvarez E, Artigas F.
    J Clin Psychopharmacol; 1992 Oct 13; 12(5):309-15. PubMed ID: 1282522
    [Abstract] [Full Text] [Related]

  • 32. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS, Lerfald SC, Bennett B, Laux D, Devereaux E, Kayser A, Corcella J, Albright D.
    Psychopharmacol Bull; 1991 Oct 13; 27(1):31-9. PubMed ID: 1862204
    [Abstract] [Full Text] [Related]

  • 33. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB, Pandey GN, Janicak PG, Sharma R, Boshes RA, Chang SS, Gierl BL, Davis JM.
    J Clin Psychiatry; 1990 Feb 13; 51(2):47-50. PubMed ID: 2298705
    [Abstract] [Full Text] [Related]

  • 34. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L.
    J Clin Psychiatry; 1984 Sep 13; 45(9):385-6. PubMed ID: 6432772
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A, Robinson DS, Yingling K, Howard DB, Corcella J, Laux D.
    J Clin Psychopharmacol; 1988 Aug 13; 8(4):246-53. PubMed ID: 3062042
    [Abstract] [Full Text] [Related]

  • 37. An outpatient evaluation of phenelzine and imipramine.
    Davidson J, Raft D, Pelton S.
    J Clin Psychiatry; 1987 Apr 13; 48(4):143-6. PubMed ID: 3549705
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF.
    Arch Gen Psychiatry; 1983 Feb 13; 40(2):202-7. PubMed ID: 6337580
    [Abstract] [Full Text] [Related]

  • 39. Drug-responsive symptoms in melancholia.
    Nelson JC, Mazure C, Quinlan DM, Jatlow PI.
    Arch Gen Psychiatry; 1984 Jul 13; 41(7):663-8. PubMed ID: 6732425
    [Abstract] [Full Text] [Related]

  • 40. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
    Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ.
    J Clin Psychiatry; 1992 Jan 13; 53(1):5-11. PubMed ID: 1737741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.